Home › RegulatoryAdvanced Biomed Inc. - 10-Q FilingAdvanced Biomed Inc. reports Q3 2026 cash decline to $213,995 and total assets of $12.9M.SEC EDGAR · November 12, 2026, 21:01 UTCTickers: $ADVB Read the full article at SEC EDGAR